These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 982004)

  • 21. [Non-Hodgkin's lymphomas. II. Analysis of the prognostic factors in a series of 307 patients].
    García Zueco JC; Delgado MP; Giraldo MP; Perella M; Rubio-Félix D; Giralt M
    Sangre (Barc); 1992 Oct; 37(5):337-44. PubMed ID: 1293772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes.
    Wheeler C; Eickhoff C; Elias A; Ibrahim J; Ayash L; McCauley M; Mauch P; Schwartz G; Eder JP; Mazanet R; Ferrara J; Rimm IJ; Guinan E; Bierer B; Gilliland G; Churchill WH; Ault K; Parsons S; Antman K; Schnipper L; Tepler I; Gaynes L; Frei E; Kadin M; Antin J
    Biol Blood Marrow Transplant; 1997 Jun; 3(2):98-106. PubMed ID: 9267670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relevance of certain factors in the effectiveness of chemoradiotherapy for Hodgkin's disease].
    Kanaev SV; Gershanovich ML; Pozharisskiĭ KM; Girshovich MM; Golovanov SG
    Vopr Onkol; 2005; 51(1):56-9. PubMed ID: 15909808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prognostic value of beta-2-microglobulin in Hodgkin disease in young adults].
    Fleury J; Tortochaux J; Legros M; Cure H; Kwiatkowski F; Ferrière JP; Travade P; Dionet C; Gaillard G; Chassagne J
    Bull Cancer; 1994 Jul; 81(7):625-31. PubMed ID: 7742606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute.
    Petera J; Macharová H; Pohanková R; Malír A; Coupek P; Konecný M; Patera J; Pecina J; Drbal J; Koukalová H; Vásová I
    Neoplasma; 2000; 47(2):129-32. PubMed ID: 10985481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical features, treatment and prognosis of 136 patients with primary non-Hodgkin's lymphoma of the nasopharynx].
    Yuan ZY; Li YX; Zhao LJ; Gao YH; Liu XF; Gu DZ; Qian TN; Yu ZH
    Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):425-9. PubMed ID: 15355649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hodgkin's disease in children: correlation of clinical characteristics, staging procedures, and treatment at the University of Minnesota.
    McClain KL; Heise R; Day DL; Lee CK; Woods WG; Aeppli D
    Am J Pediatr Hematol Oncol; 1990; 12(2):147-54. PubMed ID: 1696073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multivariate analysis of prognostic factors in adult Hodgkin's disease.
    Dienstbier Z; Chytrý P; Hermanská Z; Melínová L; Pĕnicka P; Maríková E
    Neoplasma; 1989; 36(4):447-56. PubMed ID: 2770931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical results of 295 patients with Hodgkin's disease treated by chemotherapy-predominant comprehensive modality].
    Huang HQ; Jiang WQ; Wang W; Xu GC; Zhang L; He YJ; Sun XF; Zhou ZM; Liu DG; Xu RH; Lin TY; Teng XY; Liu MZ; Su YS; Li YH; Lin XB; Guan ZZ
    Ai Zheng; 2002 Dec; 21(12):1345-9. PubMed ID: 12520745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Generic symptoms of Hodgkin's disease in relation to other prognostic criteries (author's transl)].
    Pemsel HK; Jacobs C; Hess F; Kalbfleisch H
    Strahlentherapie; 1978 Nov; 154(11):758-65. PubMed ID: 715807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pretreatment hematocrit as an independent prognostic variable in Hodgkin's disease.
    Jaffe HS; Cadman EC; Farber LR; Bertino JR
    Blood; 1986 Aug; 68(2):562-4. PubMed ID: 3730617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Significance of metabolic parameters in Hodgkin's disease (author's transl)].
    Oertel J; Gerhartz H
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 Jun; 86(2):185-93. PubMed ID: 59479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of biochemical markers in Morbus Hodgkin.
    Dienstbier Z; Dvorák P; Vĕtrovcová E; Rezný Z; Foltýnová V
    Czech Med; 1979; 2(3):104-15. PubMed ID: 231507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Stage IIIB and IVB Hodgkin's disease. Response to chemotherapy, relapses, survival rates (author's transl)].
    Kuse R; Calavrezos A; Hinrichs A; Hausmann K
    Klin Wochenschr; 1981 Jul; 59(13):737-42. PubMed ID: 6166788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prognostic factors concerning the survival time of Hodgkin's disease stage III and IV, treated with cytostatic agents].
    Stoller U; Brunner K
    Schweiz Med Wochenschr; 1976 Apr; 106(15):507-13. PubMed ID: 982004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients.
    Brice P; Bastion Y; Divine M; Nedellec G; Ferrant A; Gabarre J; Reman O; Lepage E; Fermé C
    Cancer; 1996 Sep; 78(6):1293-9. PubMed ID: 8826953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
    Mjaaland I; Ganser D; Freitag EM; Bohndorf W
    Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary intestinal lymphoma: clinical and therapeutic features of 32 patients.
    Zinzani PL; Magagnoli M; Pagliani G; Bendandi M; Gherlinzoni F; Merla E; Salvucci M; Tura S
    Haematologica; 1997; 82(3):305-8. PubMed ID: 9234576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.